Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat: Accelerative effect of bile on intestinal absorption of diclofenac

Drug Metabolism and Disposition

Volumn 24, Issue 2, 1996, Pages 216-220

  Tabata, Kenji ^a   Yamaoka, Kiyoshi ^a   Fukuyama, Takako ^a   Nakagawa, Terumichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BILE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG METABOLISM; ENTEROHEPATIC CIRCULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; INTESTINE TRANSIT TIME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PORTAL VEIN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BILE; DICLOFENAC; INTESTINAL ABSORPTION; LIVER; MALE; PORTAL VEIN; RATS; RATS, WISTAR; VEINS;

EID: 0030019765     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. M. Rowland: Influence of route of administration on drug availability. J. Pharm. Sci. 61, 70-74 (1972).
2. K. S. Pang and J. R. Gillette: Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism. J. Pharm. Sci. 67, 703-704 (1978).
3. P. A. Harris and S. Riegelman: Influence of the route of administration on the area under the plasma concentration-time curve. J. Pharm. Sci. 58, 71-75 (1969).
4. M. Gibaldi, R. N. Boyes, and S. Feldman: Influence of first-pass effect on availability of drugs on oral administration. J. Pharm. Sci. 60, 1338-1340 (1971).
5. J. Valles, J. Prunonosa, A. Menargues, M. Nomen, and R. Obach: Oral idazoxan bioavailability in rat: relevance of intestinal and hepatic first-pass effect. Drug Metab. Dispos. 17, 673-676 (1994).
6. B. Kuo, J. C. Poole, K. Hwang, and H. Cheng: Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats. J. Pharm. Sci. 83, 386-390 (1971).
7. H. Yuasa, K. Matsuda, and J. Watanabe: Influence of anesthetic regimens on intestinal absorption in rats. Pharm. Res. 10, 884-888 (1993).
8. G. Levy and W. J. Jusco: Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55, 285-289 (1966).
9. L. F. Prescott, R. F. Steel, and W. R. Ferrier: The effects of particle size on the absorption of phenacetine in man et al. Clin. Pharmacol. Ther. 11, 496-504 (1970).
10. W. L. Chiou and S. Riegelman: Absorption characteristics of solid dispersed and micronized griseofulvin in man. J. Pharm. Sci. 60, 1376-1380 (1971).
11. P. Singh, J. K. Guillory, T D. Sokoloski, L. Z. Benet, and V. N. Bhatia: Effect of inert tablet ingredients on drug absorption. I. J. Pharm. Sci. 55, 63-68 (1966).
12. W. H. Barr, J. Adir, and L. Garrettson: Decrease of tetracycline absorption in man by sodium bicarbonate Clin. Pharmacol. Ther. 12, 779-784 (1971).
13. C. D. Klaassen and J. B. Watkins: Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol. Rev. 36, 1-67 (1984).
14. D. M. Small, R. H. Dowling, and R. N. Redinger: The enterohepatic circulation of bile acid. Arch. Intern. Med. 130, 552-573 (1972).
15. R. H. Dowling: The enterohepatic circulation. Gastroenterology 62, 122-140 (1972).
16. T. R. Bates, M. Gibaldi, and J. L. Kanig: Rate of dissolution of griseofulvin and hexoesterol in bile salt solutions. Nature 210, 1331-1332 (1966).
17. T. R. Bates, M. Gibaldi, and J. L. Kanig: Solubilizing properties of bile salt solution. I. Effect of temperature and bile salt concentration on solubilization of glutethimide. griseofulvin. and hexesterol. J. Pharm. Sci. 55, 191-199 (1966).
18. T. R. Bates, M. Gibaldi, and J. L. Kanig: Solubilizing properties of bile sail solution. II. Effect of inorganic electrolyte, lipids. and a mixed bile salt system on solubulization of glutethimide, griseofulvin, and hexesterol. J. Pharm. Sci. 55, 901-906 (1966).
19. D. Shinkuma, T. Hamagchi, Y. Yamanaka, N. Mizuno, and N. Yata: Influence of bile on the gastrointestinal absorption of phenytoin in rats. Chem. Pharm. Bull. 33, 5023-5072 (1985).
20. M. Ohtani, H. Kotani, K. Uchino, Y. Sawada, and T. Iga: Pharmacokinetics analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug Metab. Dispos. 22, 2-7 (1994).
21. T. Tsuchiya, M. Terekawa, K. Ishibashi, H. Noguti, and R. Kato: Disposition and enterohepatic circulation of diclofenac in dogs. Arzneim.-Forsch./Drug Res. 30, 1650-1653 (1980).
22. T. Fukuyama, K. Yamaoka, Y. Ohata, and T. Nakagawa: A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Drug Metab. Dispos. 22, 479-485 (1994).
23. H. Kotaki, Y. Yamamura, Y. Tanimura, Y. Saitoh, F. Nakagawa, and Z. Tamura: Enterohepatic circulation of clioqinol in the rat. J. Pharm. Dyn. 7, 420-425 (1984).
24. K. Singh, J. M. Orr, and F. S. Abbot: Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat. Drug Metab. Dispos. 16, 848-852 (1988).
25. T. A. Shepard and R. H. Reuning: An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination. Pharm. Res. 4, 195-199 (1987).
26. K. Tabata, K. Yamaoka, T. Fukuyama, and T. Nakagawa: Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac. Pharm. Res. 12, 880-883 (1995).
27. D. J. Hoffman, T. Seifert, A. Borre, and H. N. Nellans: Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling. Pharm. Res. 12, 889-894 (1995).
28. M. R. Uhing and R. E. Kimura: Active transport of 3-o-methyl-glucose by the small intestines in chronically catheterized rats. J. Clin. Invest. 95, 2799-2805 (1995).
29. T. Suzuki, Y. Saitoh, S. Isozaki, and R. Ishida: Drug absorption and metabolism study by use of portal vein infusion in the rat I. Pyloric vein cannulation and its application to study of first-pass effect on bioavailability of propranolol Chem. Pharm. Bull. 20, 2731-2735 (1972).
30. Y. M. El-Sayed, M. E. Abdel-Hameed, M. S. Suleiman, and N. M. Najib: A rapid and sensitive high-performance liquid Chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies. J. Pharm. Pharmacol. 40, 727-729 (1988).
31. B. Davies and T. Morris: Physiological parameters in laboratory animals and humans. Pharm. Res. 10, 1093-1095 (1993).
32. K. Yamaoka, T. Nakagawa, and T. Uno: Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6, 547-558 (1978).
33. J. E. Peris-Ribera, F. Torres-Molina, M. C. Garcia-Carbonell, J. C. Aristorena, and J. M. Pla-Delfina: Pharmacokinetics and bioavailability of diclofenac in the rat. J. Pharmacokinet. Biopharm. 19, 647-665 (1991).
34. T. Kakutani, E. Nara, and M. Hashida: Statistical moment and disposition parameters in a local perfusion system under mammillary nonequilibrium condition. J. Pharmacokinet. Biopharm. 18, 449-458 (1990).